Elad Bergman

Title: Elad Bergman: Innovator in Retinal Disease Monitoring

Introduction

Elad Bergman is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of medical technology, particularly in the monitoring of retinal diseases. His innovative approach combines advanced imaging techniques with practical applications to improve patient outcomes.

Latest Patents

Elad Bergman holds 1 patent for his invention titled "OCT guided therapy." This patent describes systems and methods for monitoring the state of a subject's retinal disease using remote-based optical coherence tomography (OCT) imaging. The method involves receiving OCT image data of a subject's retina during a series of imaging sessions. The data is processed to determine measured extent values, which indicate the severity of the retinal disease.

Career Highlights

Bergman is currently associated with Notal Vision Inc., a company dedicated to advancing eye care through innovative technologies. His work focuses on enhancing the accuracy and efficiency of retinal disease monitoring, which is crucial for timely interventions and treatment.

Collaborations

Elad collaborates with notable professionals in the field, including Amit Pascal and Kester Nahen. Their combined expertise contributes to the development of cutting-edge solutions in retinal health.

Conclusion

Elad Bergman's contributions to the field of retinal disease monitoring exemplify the impact of innovation in healthcare. His work not only advances medical technology but also enhances the quality of life for patients suffering from retinal conditions.